Walgreen Co. Can't Trademark Store-Brand Zyrtec
The U.S. Patent and Trademark Office has rejected Walgreen Co.'s bid to sell its store-brand version of the allergy drug Zyrtec under the name Wal-Zyr, rejecting the retailer's survey evidence showing...To view the full article, register now.
Already a subscriber? Click here to view full article